Real-world patient data is revolutionizing clinical trials
The FDA granted Pfizer’s Ibrance a label indication based on real-world data from men using the drug off-label to treat their breast cancer.
Print Issue: February 01, 2020
Trading data privacy for healthy habits
With apps that facilitate new year’s resolutions come a host of data and privacy trade-offs.
Snoozing and losing: Pharma must engage Hispanic patients now
Beatriz Mallory is SVP, managing director at SensisHealth.
Inside Montel Williams’ journey from long-undiagnosed patient to MS activist
Williams endured pain in his lower extremities and temporary blindness in one eye as doctor after doctor failed to diagnose him with relapsing-remitting multiple sclerosis.
